Company Smp Clinical Development Srl with Fiscal Code 15225028
recorded a turnover of 2024 of
53.163,
with a net profit of
19.366
and having an average number of employees of
2.
The company operates in the field of Prelucrarea datelor, administrarea paginilor web si activitati conexe having the NACE code 6311.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Smp Clinical Development Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
70.825
82.521
201.559
172.898
99.217
32.097
47.645
48.662
74.323
53.163
Total Income - EUR
72.653
83.412
203.654
174.936
104.640
36.367
51.241
50.415
75.554
53.491
Total Expenses - EUR
38.964
36.804
49.939
61.492
48.701
30.603
33.812
34.268
36.157
33.657
Gross Profit/Loss - EUR
33.689
46.608
153.716
113.444
55.939
5.764
17.430
16.147
39.397
19.834
Net Profit/Loss - EUR
27.390
44.957
151.700
111.715
54.909
5.438
16.935
15.670
38.668
19.366
Employees
2
2
2
2
2
2
3
3
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -28.1%, from 74.323 euro in the year 2023, to 53.163 euro in 2024.
The Net Profit decreased by -19.086 euro, from 38.668 euro in 2023, to 19.366 in the last year.
Check the financial reports for the company - Smp Clinical Development Srl
Financial Rating - SMP CLINICAL DEVELOPMENT SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Smp Clinical Development Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Smp Clinical Development Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Smp Clinical Development Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Smp Clinical Development Srl - CUI 15225028
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
21.081
16.153
12.015
7.242
2.637
756
1.407
1.822
7.336
57.070
Current Assets
36.400
51.453
141.478
209.529
221.054
201.622
108.581
72.682
34.756
8.316
Inventories
24
14
14
26
13
71
0
0
0
0
Receivables
13.427
13.037
17.814
16.000
3.547
3.517
5.345
3.870
7.373
1.806
Cash
22.949
38.403
123.651
193.503
217.494
198.034
103.236
68.812
27.384
6.510
Shareholders Funds
51.667
66.036
151.779
215.468
221.840
201.236
108.431
71.673
40.078
59.220
Social Capital
67
67
66
64
63
62
61
61
61
60
Debts
5.813
1.570
1.714
1.303
1.852
1.141
1.557
2.844
2.014
1.253
Income in Advance
0
0
0
0
0
0
0
0
0
4.913
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"6311 - 6311"
CAEN Financial Year
6311
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
8.316 euro in 2024 which includes Inventories of
0 euro, Receivables of
1.806 euro and cash availability of
6.510 euro.
The company's Equity was valued at
59.220 euro, while total Liabilities amounted to
1.253 euro.
Equity increased by 19.366 euro, from 40.078 euro in 2023, to 59.220 in 2024.
The Debt Ratio was 1.9% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Smp Clinical Development Srl